Abstract

In the management of invasive group A streptococcal (iGAS) infection, outstanding issues are whether adding clindamycin improves outcomes over β-lactam

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call